← The Wire
EBSNYSE
Emergent BioSolutions Inc.
Pharmaceutical Preparations · DE · CIK 1367644
Provides innovative solutions for public health threats through products and contract manufacturing services
$429M
Market cap
$8.46
Last close
-0.8%
1D
+7.8%
5D
695K
Volume
Price · last 39 sessions-0.9%
May 4L $7.75 · H $9.50Jun 29
285
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 28, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 22, 2026DEFA14ADEFA14AApr 16, 2026DEFA14ADEFA14AApr 16, 2026DEFA14ADEFA14AMar 20, 2026DEFA14ADEFA14AMar 21, 2025DEFA14ADEFA14AApr 11, 2024DEFA14ADEFA14AApr 14, 2023DEFA14ADEFA14AApr 15, 2022DEFA14ADEFA14AApr 9, 2021DEFA14ADEFA14AApr 9, 2020DEFA14ADEFA14AApr 12, 2019DEFA14ADEFA14AApr 13, 2018DEFA14ADEFA14AApr 13, 2017
Insider Activity
In the 90 days to Dec 5, 2025: 4 sold $842K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Richard RonaldDirector | Sell | 14,884 | $11.90 | $177K |
| Dec 5, 2025 | Richard RonaldDirector | Sell | 7,100 | $12.11 | $86K |
| Nov 10, 2025 | Degolyer Donald WDirector | Sell | 17,801 | $10.54 | $188K |
| Nov 7, 2025 | Dayal Sujata TyagiDirector | Sell | 8,552 | $10.00 | $86K |
| Oct 7, 2025 | Glessner ColeenEVP, Quality & Ethics, and CPL | Sell | 30,608 | $10.00 | $306K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance